XML 27 R15.htm IDEA: XBRL DOCUMENT
v3.21.2

Derivative | 6 Months Ended
--- | ---
Jun. 29, 2021
Derivative |
Derivative | 7. Derivative ​ On June 22, 2021, we terminated our interest rate swap agreement at a cost of $2.4 million. This interest rate swap, which would have matured on April 1, 2025, was established to manage our exposure to interest rate movements on our Revolving Facility. The interest rate swap entitled us to receive a variable rate of interest based on the one-month LIBO rate in exchange for the payment of a fixed interest rate of 0.802%. The notional amount of the swap agreement was $280.0 million through March 31, 2023 and $140.0 million from April 1, 2023 through April 1, 2025. The differences between the variable LIBO rate and the interest rate swap rate were settled monthly. Prior to termination, the interest rate swap was determined to be an effective hedging agreement. ​ Our only derivative was the aforementioned interest rate swap, which is designated as a cash flow hedge. No gains or losses representing amounts excluded from the assessment of effectiveness were recognized in earnings in the first two quarters of fiscal 2021 or fiscal 2020. ​ The following table summarizes the changes in accumulated other comprehensive income/(loss) ("AOCI"), net of tax, related to the interest rate swap (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Twenty-Six | ​ | Twenty-Six
​ |  | Weeks Ended |  | Weeks Ended
​ | ​ | June 29, 2021 | ​ | June 30, 2020
Beginning balance | ​ | $ | (3,464) | ​ | $ | —
Other comprehensive loss before reclassifications | ​ |  | 2,514 | ​ | ​ | (4,045)
Amounts reclassified from AOCI | ​ |  | 950 | ​ | ​ | 208
Other comprehensive loss, net of tax | ​ |  | 3,464 | ​ | ​ | (3,837)
Ending balance | ​ | $ | — | ​ | $ | (3,837)
​ We classified this interest rate swap within Level 2 of the valuation hierarchy described in Note 2. Our counterparty under this arrangement provided monthly statements of the market values of this instrument based on significant inputs that were observable or could be derived principally from, or corroborated by, observable market data for substantially the full term of the asset or liability. The impact on the derivative liability for our and the counterparty’s non-performance risk to the derivative trade was considered when measuring the fair value of derivative liability.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration